Montelukast decreased exhaled nitric oxide in children with perennial allergic rhinitis

Pediatrics International

Volumn 49, Issue 3, 2007, Pages 322-327

  Hung, Chih Hsing ^a,b   Hua, Yi Ming ^c   Hsu, Wan Ting ^b   Lai, Yuan Sheng ^c   Yang, Kuender D ^d   Jong, Yuh Jyh ^a,b   Chu, Yu Te ^b  

^a Department of Otorhinolaryngology Head and Neck Surgery   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^d CHANG GUNG CHILDREN S HOSPITAL   (Taiwan)

Author keywords

Allergic rhinitis; Budesonide; Exhaled nitric oxide; Loratadine; Montelukast

Indexed keywords

BUDESONIDE; CROMOGLYCATE DISODIUM; LORATADINE; MONTELUKAST; NITRIC OXIDE;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; BRONCHUS HYPERREACTIVITY; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; EXPIRATORY FLOW RATE; FEMALE; HAY FEVER; HUMAN; IMMUNOTHERAPY; MALE; OUTPATIENT CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT INFECTION; SINGLE BLIND PROCEDURE; TREATMENT DURATION; TREATMENT OUTCOME;

ACETATES; ADMINISTRATION, INTRANASAL; ADMINISTRATION, ORAL; ADOLESCENT; ANTI-ALLERGIC AGENTS; ANTI-ASTHMATIC AGENTS; BREATH TESTS; BUDESONIDE; CHILD; CHILD, PRESCHOOL; CROMOLYN SODIUM; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HUMANS; LEUKOTRIENE ANTAGONISTS; LORATADINE; MALE; NITRIC OXIDE; PEAK EXPIRATORY FLOW RATE; QUINOLINES; RHINITIS, ALLERGIC, PERENNIAL; SINGLE-BLIND METHOD; TREATMENT OUTCOME;

EID: 34249083405     PISSN: 13288067     EISSN: 1442200X     Source Type: Journal    
DOI: 10.1111/j.1442-200X.2007.02375.x     Document Type: Article

References (31)

1. Silkoff PE, McClean PA, Slutsky AS et al. Marked flow-dependence of exhaled nitric oxide using a new technique to exclude nasal nitric oxide. Am. J. Respir. Crit. Care Med. 1997 155 : 260 67.
2. Baraldi E, Azzolin NM, Carra S, Dario C, Marchesini L, Zacchello F. Effect of topical steroids on nasal nitric oxide production in children with perennial allergic rhinitis: a pilotstudy. Respir. Med. 1998 92 : 558 61.
3. Gratziou C, Rovina N, Lignos M, Vogiatzis I, Roussos CH. Exhaled nitric oxide in seasonal allergic rhinitis: influence of pollen season and therapy. Clin. Exp. Allergy 2001 31 : 409 16.
4. Martin U, Bryden K, Devoy M, Howarth P. Increased levels of exhaled nitric oxide during nasal and oral breathing in subjects with seasonal rhinitis. J. Allergy Clin. Immunol. 1996 97 : 768 72.
5. Henriksen AH, Sue-Chu M, Holmen TL, Langhammer A, Bjermer L. Exhaled and nasal NO levels in allergic rhinitis: relation to sensitization, pollen season and bronchial hyperresponsiveness. Eur. Respir. J. 1999 13 : 301 6.
6. Chang YC, Hseih KH. The study of house dust mites in Taiwan. Ann. Allergy 1989 62 : 101 6.
7. Milgrom H, Biondi R, Georgitis JW et al. Comparison of ipratropium bromide 0.03% with beclomethasone dipropionate in the treatment of perennial rhinitis in children. Ann. Allergy Asthma Immunol. 1999 83 : 105 11.
8. Kharitonov SA, Yates D, Barnes PJ. Increased nitric oxide in exhaled air of normal human subjects with upper respiratory tract infections. Eur. Respir. J. 1995 8 : 295 7.
9. Tsai YG, Lee MY, Yang KD, Chu DM, Yuh YS, Hung CH. A single dose of nebulized budesonide decreases exhaled nitric oxide in children with acute asthma. J. Pediatr. 2001 139 : 433 7.
10. Gerlach H, Rossaint R, Pappert D, Knorr M, Falke KJ. Autoinhalation of nitric oxide after endogenous synthesis in nasopharynx. Lancet 1994 343 : 518 19.
11. Lundberg JO, Weitzberg E, Nordvall SL, Kuylenstierna R, Lundberg JM, Alving K. Primarily nasal origin of exhaled nitric oxide and absence in Kartagener's syndrome. Eur. Respir. J. 1994 7 : 1501 4.
12. Massaro AF, Mehta S, Lilly CM, Kobzik L, Reilly JJ, Drazen JM. Elevated nitric oxide concentrations in isolated lower airway gas of asthmatic subjects. Am. J. Respir. Crit. Care Med. 1996 153 : 1510 14.
13. Kharitonov SA, Chung KF, Evans DJ, O'Connor BJ, Barnes JP. Increased exhaled nitric oxide in asthma is mainly derived from the lower respiratory tract. Am. J. Respir. Crit. Care Med. 1996 153 : 1773 80.
14. Kim KT, Rabinovitch N, Uryniak T, Simpson B, O'Dowd L, Casty F. Effect of budesonide aqueous nasal spray on hypothalamic-pituitary-adrenal axis function in children with allergic rhinitis. Ann. Allergy Asthma Immunol. 2004 93 : 61 7.
15. Pedersen S. Assessing the effect of intranasal steroids on growth. J. Allergy Clin. Immunol. 2001 108 : S40 44.
16. Bratton DL, Lanz MJ, Miyazawa N, White CW, Silkoff PE. Exhaled nitric oxide before and after montelukast sodium therapy in school-age children with chronic asthma: a preliminary study. Pediatr. Pulmonol. 1999 28 : 402 7.
17. Jatakanon A, Lim S, Kharitonov SA, Chung KF, Barnes PJ. Correlation between exhaled nitric oxide, sputum eosinophils, and methacholine responsiveness in patients with mild asthma. Thorax 1998 53 : 91 5.
18. Baraldi E, Azzolin NM, Zanconato S, Dario C, Zaccbello F. Corticosteroids decrease exhaled nitric oxide in children with acute asthma. J. Pediatr. 1997 131 : 381 5.
19. Nelson BV, Sears S, Woods J et al. Expired nitric oxide as a marker for childhood asthma. J. Pediatr. 1997 130 : 423 7.
20. Laitinen LA, Laitinen A, Haahtela T, Vikka V, Spur BW, Lee TH. Leukotriene E4 and granulocytic infiltration into asthmatic airways. Lancet 1993 341 : 989 90.
21. Spada CS, Nieves LA, Krauss HP, Woodrard DF. Comparison of leukotriene E4 and D4 effects on human eosinophil and neutrophil motility in vitro. J. Leukoc. Biol. 1994 55 : 183 91.
22. Knorr B, Matz J, Bernstein JA et al. Montelukast for chronic asthma in 6- to 14-year-old children: a randomized, double-blind trial. JAMA 1998 279 : 1181 6.
23. Pizzichini E, Leff JA, Reiss TF et al. Montelukast reducesairway eosinophilic inflammation in asthma: a randomized, control trial. Eur. Respir. J. 1999 14 : 12 18.
24. Bisgaard H, Loland L, Oj JA. NO in exhaled air of asthmatic children is reduced by the leukotriene receptor antagonist montelukast. Am. J. Respir. Crit. Care Med. 1999 160 : 1227 31.
25. Diamant Z, Grootendorst DC, Veselic-Charrat M et al. Theeffect of montelukast (MK-0476), a cysteinyl leukotriene receptor antagonist, on allergen-induced airway responses and sputum cell counts in asthma. Clin. Exp. Allergy 1999 29 : 42 51.
26. Dockhorn RJ, Baumgartner RA, Leff JA et al. Comparison of the effects of intravenous and oral montelukast on airway function: a double blind, placebo controlled, three period, crossover study in asthmatic patients. Thorax 2000 55 : 260 65.
27. Carra S, Gagliard L, Zanconato S et al. Budesonide but notnedocromil sodium reduces exhaled nitric oxide levels in asthmatic children. Respir. Med. 2001 95 : 934 9.
28. Armenio L, Baldini G, Bardare M et al. Double blind, placebo controlled study of nedocromil sodium in asthma. Arch. Dis. Child. 1993 68 : 193 7.
29. Schuller DE, Selcow JE, Joos TH et al. A multicenter trial of nedocromil sodium, 1% nasal solution, compared with cromolyn sodium and placebo in ragweed seasonal allergic rhinitis. J. Allergy Clin. Immunol. 1990 86 : 554 61.
30. Tasche MJA, Uijen JHJM, Bernsen RMD, de Jongste JC, van der Wouden JC. Inhaled disodium cromoglycate (DSCG) as maintenance in children with asthma: a systemic review. Throax 2000 55 : 913 20.
31. Palma-Carlos AG, Chieira C, Conde TA, Cordeiro JAR. Double-blind comparison of levocabastine nasal spray with sodium cromoglycate nasal spray in the treatment of seasonal allergic rhinitis. Ann. Allergy 1991 67 : 394 8.